KIROMIC BIOPHARMA
Kiromic exists to create a robust diagnostic and therapeutic program for solid tumors and hematologic malignancies based on its portfolio of patented cancer-associated biomarkers and small molecules. Kiromic aims to develop clinical diagnostic tools for rapid detection of cancer-associated antigens, which may translate into earlier diagnosis and accurate monitoring of response to cancer treatments. Their cancer-associated biomarkers also allow for the design and development of personalized, cancer-specific targeted immunotherapy strategies that may improve patient outcomes and result in less suffering and longer survival times.
KIROMIC BIOPHARMA
Industry:
Bioinformatics Biopharma Biotechnology Health Care Life Science Pharmaceutical Therapeutics
Founded:
2012-01-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.kiromic.com
Total Employee:
11+
Status:
Active
Contact:
806-252-5845
Email Addresses:
[email protected]
Total Funding:
53.24 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
ImmunoBiochem Corporation
ImmunoBiochem is developing novel tumor microenvironment-targeted biological therapeutics for solid tumor indications.
Nurix Therapeutics
Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2021-06-14 | In Silico Solutions | In Silico Solutions acquired by Kiromic Biopharma | N/A |
Key Employee Changes
Date | New article |
---|---|
2022-07-12 | Kiromic BioPharma Appoints Leonardo Mirandola, Ph.D. as Chief Scientific Officer |
2021-10-05 | Kiromic BioPharma Announces Chief Financial Officer Transition |
Official Site Inspections
http://www.kiromic.com Semrush global rank: 6.92 M Semrush visits lastest month: 694
- Host name: host2001.hostmonster.com
- IP address: 67.20.76.53
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "Kiromic Biopharma"
Kiromic Biopharma - Crunchbase Company Profile & Funding
Kiromic exists to create a robust diagnostic and therapeutic program for solid tumors and hematologic malignancies based on its portfolio of patented cancer-associated biomarkers and โฆSee details»
Kiromic Company Profile | Management and Employees List
Kiromic is in the process of developing ALEXIS, a multi-indication allogeneic CAR-T cell therapy platform that exploits the natural potency of g amma delta T-cells to target solid cancers. โฆSee details»
KIROMIC, LLC - VentureRadar
" Kiromic BioPharma, Inc. is a clinical-stage, fully integrated biotherapeutics company using its proprietary DIAMOND® artificial intelligence (AI) platform to discover and develop cell and โฆSee details»
Kiromic Biopharma - Org Chart, Teams, Culture & Jobs - The Org
Kiromic Biopharma is an immuno-oncology, target discovery, and gene editing company developing highly effective and safe tumor-specific cancer engineered immunotherapies to โฆSee details»
Working At Kiromic: Company Overview and Culture - Zippia
Kiromic is a small professional company based in Houston, TX with only 50 employees and an annual revenue of $1.0B. Kiromic's Mission Statement Test products to be created by the joint โฆSee details»
Kiromic - Golden
Organization. Company attributes. Industry. Molecular biology. 0. Bioinformatics. Healthcare. Pharmaceutical industry. Life science. ... Kiromic BioPharma, Inc. is an immuno-oncology โฆSee details»
Kiromic Biopharma Company Profile - Office Locations ... - Craft
Sep 20, 2024 Kiromic BioPharma (formerly known as Kiromic) is a target discovery and gene editing company focusing on developing immuno-oncology therapeutics for the treatment of โฆSee details»
Board of Directors - Kiromic BioPharma, Inc.
Mr. Bersani has served as a member of our Board since June 2020. The Company appointed Mr. Bersani Chief Executive Officer effective May 10, 2022.See details»
Overview - Kiromic
In order to overcome this challenge, Kiromic BioPharma, Inc. has developed a number of therapies to equip the immune system with the right tools for fighting cancer. Acute โฆSee details»
Kiromic BioPharma Announces Changes in Management, Board of โฆ
Jan 27, 2022 Kiromic BioPharma, Inc. is a clinical-stage, fully integrated biotherapeutics company using its proprietary DIAMOND® artificial intelligence (AI) platform to discover and โฆSee details»
Kiromic - Company Profile - Tracxn
Dec 5, 2024 Kiromic - Developer of small molecules-based therapeutic solutions for the treatment of cancer. Public Company. Raised a total funding of $135K over 1 round. Founded โฆSee details»
Kiromic Company Profile 2024: Stock Performance & Earnings
Kiromic General Information Description. Kiromic BioPharma Inc is a biotechnology company. It is an artificial intelligence (AI) driven, end-to-end allogeneic cell therapy company, currently โฆSee details»
Leadership - Kiromic
Before joining Kiromic, Dr. Mirandola was a post-doctoral research scientist at Texas Tech University Health Sciences Center. He earned an M.S. in Medical Biotechnologies and a Ph.D. โฆSee details»
Kiromic BioPharma, Inc.
Kiromic BioPharma, Inc. (Exact name of registrant as specified in its charter) De l aware 46-4762913 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer โฆSee details»
Kiromic Biopharma - Contacts, Employees, Board Members
Organization. Kiromic Biopharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... Kiromic Biopharma has 1 โฆSee details»
SEC.gov | SEC Charges Kiromic BioPharma and Two Former C-Suite ...
Dec 3, 2024 The Securities and Exchange Commission today filed settled charges against Houston-based biotherapeutics company Kiromic BioPharma, Inc., its former CEO, Maurizio โฆSee details»
Kiromic Biopharma settles SEC charges over misleading investors ...
Dec 3, 2024 The SEC said Kiromic was not ordered to pay a civil penalty because the company had self-reported the incident, and Chiriva and Tontat agreed to pay civil penalties of $125,000 โฆSee details»
Kiromic BioPharma Reports Fourth Quarter and Full-Year 2021 โฆ
Dec 31, 2021 Kiromic BioPharma, Inc. is a clinical-stage, fully integrated biotherapeutics company using its proprietary DIAMOND ® artificial intelligence (AI) platform to discover and โฆSee details»
Drug Development Pipeline - Kiromic
First patient Nov 2023 FTD Aug 2024 Expansion phase started in Sep 2024: Isocelโข Alone or in combination with Low-Dose Radiation* Allogeneic, off-the-shelf, Viral vector-free GDT CAR-T โฆSee details»